Technetium-99m tetrofosmin uptake in insular thyroid carcinoma - A comparison with iodine-131

Degirmenci B., Aydin A., Comlekci A., Ozdogan Ö., BEKİŞ R.

CLINICAL NUCLEAR MEDICINE, vol.28, no.5, pp.385-388, 2003 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 28 Issue: 5
  • Publication Date: 2003
  • Doi Number: 10.1097/00003072-200305000-00004
  • Journal Name: CLINICAL NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.385-388
  • Dokuz Eylül University Affiliated: Yes

Abstract

The authors describe a 42-year-old man with insular thyroid carcinoma. In this patient, iodine-131 (I-131) and technetium-99m (Tc-99m) tetrofosmin imaging were performed to investigate residual thyroid tissue and metastatic foci of tumor. Both I-131 and Tc-99m tetrofosmin images showed metastatic foci, but Tc-99m tetrofosmin imaging revealed the lesions better than did the I-131 scan. Tc-99m tetrofosmin imaging does not require withholding of thyroid hormone suppression and can be used for follow-up evaluation of patients with insular thyroid carcinoma.